Cardiol Therapeutics Files 6-K Report
Ticker: CRDL · Form: 6-K · Filed: Mar 3, 2025 · CIK: 1702123
| Field | Detail |
|---|---|
| Company | Cardiol Therapeutics INC. (CRDL) |
| Form Type | 6-K |
| Filed Date | Mar 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, regulatory-update, news-release
Related Tickers: CRDL
TL;DR
Cardiol Therapeutics (CRDL) filed a 6-K on March 3rd, check for news release updates.
AI Summary
Cardiol Therapeutics Inc. filed a Form 6-K on March 3, 2025, reporting information for the month of March 2025. The filing includes a news release dated March 3, 2025, as Exhibit 99.1. The company is incorporated in Ontario, Canada, and its principal executive offices are located in Oakville.
Why It Matters
This filing provides an update on Cardiol Therapeutics' corporate activities and may contain important news or disclosures relevant to investors.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that typically contains press releases or other periodic information, not usually indicative of immediate high risk.
Key Players & Entities
- Cardiol Therapeutics Inc. (company) — Registrant
- March 3, 2025 (date) — Filing date and news release date
- Oakville, Ontario, Canada (location) — Principal executive offices
- 001-40712 (other) — Commission File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically used to furnish information that the registrant may be required to disclose to its security holders.
What specific exhibit is included with this 6-K filing?
This filing includes Exhibit 99.1, which is a News Release dated March 3, 2025.
Where are Cardiol Therapeutics Inc.'s principal executive offices located?
Cardiol Therapeutics Inc.'s principal executive offices are located at 602-2265 Upper Middle Road East, Oakville, Ontario, Canada L6H 0G5.
What is the Commission File Number for Cardiol Therapeutics Inc.?
The Commission File Number for Cardiol Therapeutics Inc. is 001-40712.
Does Cardiol Therapeutics Inc. file annual reports under Form 20-F or Form 40-F?
Cardiol Therapeutics Inc. indicates that it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 3, 2025 regarding Cardiol Therapeutics Inc. (CRDL).